GLOBAL BOTULINUM TOXIN MARKET 2021-2028

Lifesciences | Healthcare & Wellness

GLOBAL BOTULINUM TOXIN MARKET 2021-2028

Market by Type, Application, End-user, and Regional Outlook | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton Market Research predicts that the global botulinum toxin market is anticipated to rise with a CAGR of 5.55% during the forecast period 2021-2028. The market was valued at $2327.91 million in the year 2020, and is expected to rise to a revenue of about $4744.35 million by the year 2028.


Report scope can be customized per your requirements. Request For Customization

Triton’s report on the botulinum toxin market provides an in-depth insight into the market. The detailed analysis of the market includes key market insights, Porter’s five forces analysis, key impact analysis, and market attractiveness index.  

Factors such as the increasing demand for aesthetic procedures and the expansion of botulinum toxin into therapeutic applications are expected to foster the growth of the market during the forecast period. The demand for aesthetic procedures is increasing, and it is expected to continue to grow in the near future. Moreover, there is an increase in people’s concern regarding their appearance in developed as well as developing regions. Furthermore, the rising awareness regarding various cosmetic procedures to reduce aging signs, especially in women, is expected to drive market growth.

Furthermore, the increasing aging population and rise in medical tourism are expected to act as some opportunities for the market. There are continuous advancements in the medical field aesthetics, which help the aging population to live a healthy, more active, and enjoy a younger lifestyle. Botulinum toxin has been known to give patients a more youthful appearance, and new studies show that it can actually slow down the aging process. Therefore, the increase in the aging population results in the growth of the market.

The upgrades and continuous changes in reimbursement policies act as restraining factors for the botulinum toxin market. The current trend of healthcare, reimbursement, coverage reform, payer & provider consolidation, and escalating healthcare costs will allow lesser adoption to the newer advanced botulinum toxin products and impede the market’s growth. Furthermore, the adverse effects associated with botulinum toxin and the lack of interchangeability between botulinum toxin products are some of the key restraining factors of the botulinum toxin market.



Key geographies covered in the global botulinum toxin market are:

•           North America: United States and Canada

•           Europe: United Kingdom, France, Germany, Spain, Italy, Russia, and Rest of Europe

•           Asia-Pacific: China, Japan, India, Australia, South Korea, ASEAN Countries, and Rest of Asia-Pacific

•           Latin America: Brazil, Mexico, and Rest of Latin America

•           Middle East and Africa: Saudi Arabia, Turkey, United Arab Emirates, South Africa, and Rest of Middle East & Africa

The segmentation analysis of the botulinum toxin market includes:

•           Type is sub-segmented into:

o          Type A

o          Type B

•           Application is sub-segmented into:

o          Cosmetic Applications

•           Glabellar Lines        

•           Lateral Canthal Lines (Crow’s Feet)        

•           Forehead Lines       

•           Other Cosmetic Applications

o          Non-cosmetic Applications

•           Dystonia       

•           Chronic Migraine    

•           Ophthalmologic Disorders 

•           Other Non-Cosmetic Applications

•           End-users is sub segmented into:

o          Hospitals

o          Clinics and Others

The key companies profiled in the report include Evolus Inc, Revance Therapeutics Inc, Ipsen Pharma, Hugel Inc, Galderma Pharma SA (Acquired By EQT), Medytox Inc, Abbvie Inc (Allergan Plc), US WorldMeds LLC, and Merz Pharma.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. GLOBAL BOTULINUM TOXIN MARKET – SUMMARY      

2. INDUSTRY OUTLOOK  

2.1. KEY INSIGHTS      

2.1.1. SURGE IN DISPOSABLE INCOME         

2.1.2. GROWING NUMBER OF MEN OPTING FOR COSMETIC TREATMENT   

2.1.3. DEVELOPMENT OF HEALTHCARE INFRASTRUCTURE    

2.2. IMPACT OF COVID-19 ON THE BOTULINUM TOXIN INDUSTRY

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS    

2.3.2. THREAT OF SUBSTITUTE

2.3.3. BARGAINING POWER OF SUPPLIERS

2.3.4. BARGAINING POWER OF BUYERS      

2.3.5. THREAT OF COMPETITIVE RIVALRY  

2.4. MARKET ATTRACTIVENESS MATRIX

2.5. VENDOR SCORECARD 

2.6. KEY MARKET STRATEGIES     

2.6.1. NEW PRODUCT LAUNCHES      

2.7. MARKET DRIVERS         

2.7.1. INCREASING DEMAND FOR AESTHETIC PROCEDURES 

2.7.2. EXPANSION OF BOTULINUM TOXIN INTO THERAPEUTIC APPLICATIONS     

2.8. MARKET RESTRAINTS  

2.8.1. ADVERSE EFFECTS ASSOCIATED WITH BOTULINUM TOXIN     

2.8.2. LACK OF REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES   

2.8.3. LACK OF INTERCHANGEABILITY BETWEEN BOTULINUM TOXIN PRODUCTS

2.9. MARKET OPPORTUNITIES       

2.9.1. INCREASING AGING POPULATION      

2.9.2. RISE IN MEDICAL TOURISM       

3. GLOBAL BOTULINUM TOXIN MARKET – BY TYPE         

3.1. TYPE A       

3.2. TYPE B       

4. GLOBAL BOTULINUM TOXIN MARKET – BY APPLICATION     

4.1. COSMETIC APPLICATIONS      

4.1.1. GLABELLAR LINES

4.1.2. LATERAL CANTHAL LINES (CROW’S FEET)  

4.1.3. FOREHEAD LINES 

4.1.4. OTHER COSMETIC APPLICATIONS     

4.2. NON-COSMETIC APPLICATIONS        

4.2.1. DYSTONIA   

4.2.2. CHRONIC MIGRAINE        

4.2.3. OPHTHALMOLOGIC DISORDERS         

4.2.4. OTHER NON-COSMETIC APPLICATIONS       

5. GLOBAL BOTULINUM TOXIN MARKET – BY END-USER          

5.1. HOSPITALS           

5.2. CLINICS AND OTHERS  

6. GLOBAL BOTULINUM TOXIN MARKET – REGIONAL OUTLOOK         

6.1. NORTH AMERICA

6.1.1. MARKET BY TYPE 

6.1.2. MARKET BY APPLICATION         

6.1.2.1. MARKET BY COSMETIC APPLICATIONS           

6.1.2.2. MARKET BY NON-COSMETIC APPLICATIONS 

6.1.3. MARKET BY END-USER  

6.1.4. COUNTRY ANALYSIS       

6.1.4.1. UNITED STATES       

6.1.4.2. CANADA         

6.2. EUROPE    

6.2.1. MARKET BY TYPE 

6.2.2. MARKET BY APPLICATION         

6.2.2.1. MARKET BY COSMETIC APPLICATIONS           

6.2.2.2. MARKET BY NON-COSMETIC APPLICATIONS 

6.2.3. MARKET BY END-USER  

6.2.4. COUNTRY ANALYSIS       

6.2.4.1. UNITED KINGDOM    

6.2.4.2. GERMANY      

6.2.4.3. FRANCE          

6.2.4.4. SPAIN  

6.2.4.5. ITALY    

6.2.4.6. RUSSIA

6.2.4.7. REST OF EUROPE   

6.3. ASIA-PACIFIC       

6.3.1. MARKET BY TYPE 

6.3.2. MARKET BY APPLICATION         

6.3.2.1. MARKET BY COSMETIC APPLICATIONS           

6.3.2.2. MARKET BY NON-COSMETIC APPLICATIONS 

6.3.3. MARKET BY END-USER  

6.3.4. COUNTRY ANALYSIS       

6.3.4.1. CHINA  

6.3.4.2. JAPAN 

6.3.4.3. INDIA    

6.3.4.4. SOUTH KOREA         

6.3.4.5. ASEAN COUNTRIES

6.3.4.6. AUSTRALIA & NEW ZEALAND      

6.3.4.7. REST OF ASIA-PACIFIC      

6.4. LATIN AMERICA  

6.4.1. MARKET BY TYPE 

6.4.2. MARKET BY APPLICATION         

6.4.2.1. MARKET BY COSMETIC APPLICATIONS           

6.4.2.2. MARKET BY NON-COSMETIC APPLICATIONS 

6.4.3. MARKET BY END-USER              

6.4.4. COUNTRY ANALYSIS       

6.4.4.1. BRAZIL

6.4.4.2. MEXICO           

6.4.4.3. REST OF LATIN AMERICA 

6.5. MIDDLE EAST AND AFRICA     

6.5.1. MARKET BY TYPE 

6.5.2. MARKET BY APPLICATION         

6.5.2.1. MARKET BY COSMETIC APPLICATIONS           

6.5.2.2. MARKET BY NON-COSMETIC APPLICATIONS 

6.5.3. MARKET BY END-USER              

6.5.4. COUNTRY ANALYSIS       

6.5.4.1. UNITED ARAB EMIRATES  

6.5.4.2. TURKEY          

6.5.4.3. SAUDI ARABIA          

6.5.4.4. SOUTH AFRICA         

6.5.4.5. REST OF MIDDLE EAST & AFRICA          

7. COMPETITIVE LANDSCAPE 

7.1. ABBVIE INC           

7.2. EVOLUS INC

7.3. GALDERMA PHARMA SA (ACQUIRED BY EQT)      

7.4. HUGEL INC

7.5. IPSEN PHARMA   

7.6. MERZ PHARMA   

7.7. MEDYTOX INC

7.8. REVANCE THERAPEUTICS INC

7.9. US WORLDMEDS LLC    

8. METHODOLOGY & SCOPE    

8.1. RESEARCH SCOPE & DELIVERABLES        

8.2. SOURCES OF DATA       

8.3. RESEARCH METHODOLOGY   

List of Tables

TABLE 1: GLOBAL BOTULINUM TOXIN MARKET, BY REGIONAL OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 2: MARKET ATTRACTIVENESS MATRIX

TABLE 3: VENDOR SCORECARD

TABLE 4: LIST OF NEW PRODUCT LAUNCHES

TABLE 5: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 6: GLOBAL BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 7: GLOBAL BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 8: GLOBAL BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 9: GLOBAL BOTULINUM TOXIN MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 10: GLOBAL BOTULINUM TOXIN MARKET, BY REGIONAL OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 11: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 12: NORTH AMERICA BOTULINUM TOXIN MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 13: NORTH AMERICA BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 14: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 15: NORTH AMERICA BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 16: NORTH AMERICA BOTULINUM TOXIN MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 17: EUROPE BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 18: EUROPE BOTULINUM TOXIN MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 19: EUROPE BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 20: EUROPE BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 21: EUROPE BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 22: EUROPE BOTULINUM TOXIN MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 23: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 24: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 25: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 26: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 27: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 28: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 29: LATIN AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 30: LATIN AMERICA BOTULINUM TOXIN MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 31: LATIN AMERICA BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 32: LATIN AMERICA BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 33: LATIN AMERICA BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 34: LATIN AMERICA BOTULINUM TOXIN MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 35: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 36: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 37: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 38: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 39: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 40: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1: PORTER’S FIVE FORCES ANALYSIS

FIGURE 2: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE, 2020 & 2028 (IN %)

FIGURE 3: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE A, 2021-2028 (IN $ MILLION)

FIGURE 4: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE B, 2021-2028 (IN $ MILLION)

FIGURE 5: GLOBAL BOTULINUM TOXIN MARKET, BY APPLICATION, 2020 & 2028 (IN %)

FIGURE 6: GLOBAL BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 7: GLOBAL BOTULINUM TOXIN MARKET, BY GLABELLAR LINES, 2021-2028 (IN $ MILLION)

FIGURE 8: GLOBAL BOTULINUM TOXIN MARKET, BY LATERAL CANTHAL LINES (CROW’S FEET), 2021-2028 (IN $ MILLION)

FIGURE 9: GLOBAL BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2021-2028 (IN $ MILLION)

FIGURE 10: GLOBAL BOTULINUM TOXIN MARKET, BY OTHER COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 11: GLOBAL BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 12: GLOBAL BOTULINUM TOXIN MARKET, BY DYSTONIA, 2021-2028 (IN $ MILLION)

FIGURE 13: GLOBAL BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2021-2028 (IN $ MILLION)

FIGURE 14: GLOBAL BOTULINUM TOXIN MARKET, BY OPHTHALMOLOGIC DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 15: GLOBAL BOTULINUM TOXIN MARKET, BY OTHER NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 16: GLOBAL BOTULINUM TOXIN MARKET, BY END-USER, 2020 & 2028 (IN %)

FIGURE 17: GLOBAL BOTULINUM TOXIN MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)

FIGURE 18: GLOBAL BOTULINUM TOXIN MARKET, BY CLINICS AND OTHERS, 2021-2028 (IN $ MILLION)

FIGURE 19: GLOBAL BOTULINUM TOXIN MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 20: UNITED STATES BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 21: CANADA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 22: UNITED KINGDOM BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 23: GERMANY BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 24: FRANCE BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 25: SPAIN BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 26: ITALY BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 27: RUSSIA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 28: REST OF EUROPE BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 29: CHINA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 30: JAPAN BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 31: INDIA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 32: SOUTH KOREA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 33: ASEAN COUNTRIES BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 34: AUSTRALIA & NEW ZEALAND BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 35: REST OF ASIA-PACIFIC BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 36: BRAZIL BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 37: MEXICO BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 38: REST OF LATIN AMERICA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 39: UNITED ARAB EMIRATES BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 40: TURKEY BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 41: SAUDI ARABIA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 42: SOUTH AFRICA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 43: REST OF MIDDLE EAST & AFRICA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$2,750.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$4,000.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;